From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases Review

sustainable development goals

publication date

  • September 16, 2021

webpage

published in

keywords

  • clinical trials
  • eosinophilic diseases
  • interleukin-5
  • mepolizumab
  • real-world data